Indivior (LON:INDV) Stock Price Down 5%

Indivior PLC (LON:INDV) fell 5% during trading on Monday . The company traded as low as GBX 768 ($9.96) and last traded at GBX 774 ($10.04). 1,059,445 shares changed hands during mid-day trading, an increase of 94% from the average session volume of 544,839 shares. The stock had previously closed at GBX 814.50 ($10.56).

Analyst Ratings Changes

Separately, Deutsche Bank Aktiengesellschaft lowered their price target on Indivior from GBX 2,350 ($30.48) to GBX 1,500 ($19.45) and set a “buy” rating for the company in a research report on Tuesday, July 9th.

Indivior Trading Down 5.0 %

The firm has a 50 day simple moving average of GBX 1,273.11 and a 200 day simple moving average of GBX 1,409.72. The company has a debt-to-equity ratio of 2,790.00, a quick ratio of 1.52 and a current ratio of 0.93. The firm has a market cap of £1.05 billion, a P/E ratio of 25,800.00, a P/E/G ratio of -5.57 and a beta of 0.06.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.